Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Grimaldi

Showing results (301-310 of 447) with videos related to

Pageof 45
Sort By:
Minerva Ginecologica|July 25, 2013
Long-term outcomes of perineal rehabilitationM Torella, M T Schettino, C Tammaro, et al.
Biomed Research International|May 28, 2013
Vitronectin absorbed on nanoparticles mediate cell viability/proliferation and uptake by 3T3 Swiss albino mouse fibroblasts: in vitro studyF Rosso, G Marino, A Grimaldi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1988
Lack of hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patientsI Berlin, A Grimaldi, C Landault, et al.
Presse Medicale (Paris, France : 1983)|March 14, 1987
[Exacerbation of hyperkalemia by heparinotherapy in an insulin-dependent diabetic]P Massin, A Champigneulle, A Grimaldi, et al.
Presse Medicale (Paris, France : 1983)|March 14, 1987
[Association of diabetes mellitus and gestational diabetes insipidus]A Grimaldi, A Champigneule, F Bosquet, et al.
Journal of Microscopy|December 2, 2010
Immunogold labelling in environmental scanning electron microscopy: applicative features for complementary cytological interpretationG Cafiero, F Papale, A Grimaldi, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|November 1, 1995
Are free fatty acids related to plasma plasminogen activator inhibitor 1 in android obesity?J P Bastard, E Bruckert, J J Robert, et al.
Diabetes & Metabolism|December 19, 2000
Managing type 2 diabetes in France: the ECODIA surveyB Detournay, S Cros, B Charbonnel, et al.
European Journal of Human Genetics : EJHG|December 2, 2010
Personal genetics: regulatory framework in Europe from a service provider's perspectiveKeith A Grimaldi, Markus P Look, G Antonio Scioli, et al.
Annales D'Endocrinologie|February 5, 2008
[One-year follow-up in real clinical practice conditions of type 2 diabetic patients treated with rosiglitazone: the Avantage study]G Slama, E Eschwège, M-H Bernard, et al.
Pageof 45

Showing results (301-310 of 447) with videos related to

Sort By:
Pageof 45
Minerva Ginecologica|July 25, 2013
Long-term outcomes of perineal rehabilitationM Torella, M T Schettino, C Tammaro, et al.
Biomed Research International|May 28, 2013
Vitronectin absorbed on nanoparticles mediate cell viability/proliferation and uptake by 3T3 Swiss albino mouse fibroblasts: in vitro studyF Rosso, G Marino, A Grimaldi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1988
Lack of hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patientsI Berlin, A Grimaldi, C Landault, et al.
Presse Medicale (Paris, France : 1983)|March 14, 1987
[Exacerbation of hyperkalemia by heparinotherapy in an insulin-dependent diabetic]P Massin, A Champigneulle, A Grimaldi, et al.
Presse Medicale (Paris, France : 1983)|March 14, 1987
[Association of diabetes mellitus and gestational diabetes insipidus]A Grimaldi, A Champigneule, F Bosquet, et al.
Journal of Microscopy|December 2, 2010
Immunogold labelling in environmental scanning electron microscopy: applicative features for complementary cytological interpretationG Cafiero, F Papale, A Grimaldi, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|November 1, 1995
Are free fatty acids related to plasma plasminogen activator inhibitor 1 in android obesity?J P Bastard, E Bruckert, J J Robert, et al.
Diabetes & Metabolism|December 19, 2000
Managing type 2 diabetes in France: the ECODIA surveyB Detournay, S Cros, B Charbonnel, et al.
European Journal of Human Genetics : EJHG|December 2, 2010
Personal genetics: regulatory framework in Europe from a service provider's perspectiveKeith A Grimaldi, Markus P Look, G Antonio Scioli, et al.
Annales D'Endocrinologie|February 5, 2008
[One-year follow-up in real clinical practice conditions of type 2 diabetic patients treated with rosiglitazone: the Avantage study]G Slama, E Eschwège, M-H Bernard, et al.
Pageof 45